6 results on '"Aikman N"'
Search Results
2. Early-stage serous fallopian tube carcinoma.
- Author
-
Khromchenko K, Aikman N, Sun X, and ElSahwi K
- Subjects
- Female, Humans, Fallopian Tubes surgery, Fallopian Tubes pathology, Carcinoma, Ovarian Epithelial, Hysterectomy, Fallopian Tube Neoplasms diagnosis, Fallopian Tube Neoplasms surgery, Fallopian Tube Neoplasms pathology, Ovarian Neoplasms surgery
- Abstract
Primary fallopian tube carcinoma (PFTC) is a rare disease. Its location, close association with epithelial ovarian carcinoma, and lack of specific signs and symptoms make diagnosis challenging especially in its early stages. We report a postmenopausal patient who presented with a 2-month history of abdominopelvic pain with watery vaginal discharge. Imaging findings showed a 7 cm complex left adnexal mass. The patient underwent a robotic-assisted total laparoscopic hysterectomy and bilateral salpingo-oophorectomy and surgical staging. Findings were significant for stage IA serous fallopian tube carcinoma. PFTC is sometimes missed preoperatively and intraoperatively. Available literature review has focused on the clinical and imaging characteristics of PFTC to aid in timely disease diagnosis. Minimally invasive surgery is a viable option in the diagnosis and management of early-stage ovarian cancer due to improved visualisation of pelvic structures, decreased length of hospital stay, decreased estimated blood loss and lower postoperative complication rates compared with laparotomy., Competing Interests: Competing interests: None declared., (© BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2023
- Full Text
- View/download PDF
3. Extended Venous Thromboembolism Prophylaxis after Robotic Staging for Endometrial Cancer.
- Author
-
Palmieri A, Hicks V, Aikman N, Borowsky M, Haggerty A, and ElSahwi K
- Subjects
- Female, Humans, Enoxaparin, Retrospective Studies, Anticoagulants therapeutic use, Postoperative Complications epidemiology, Postoperative Complications prevention & control, Postoperative Complications etiology, Venous Thromboembolism epidemiology, Venous Thromboembolism etiology, Venous Thromboembolism prevention & control, Robotics, Robotic Surgical Procedures adverse effects, Endometrial Neoplasms surgery, Endometrial Neoplasms pathology
- Abstract
Objectives: Our objectives were to estimate the incidence of venous thromboembolism (VTE) after robotic staging for endometrial cancer and to compare the incidence of VTE in patients who received a single dose of preoperative prophylaxis of enoxaparin with those who received extended postoperative prophylaxis., Methods: This study is a retrospective chart review of patients who underwent robot-assisted surgical staging for endometrial cancer. Patients were categorized into two groups: preoperative prophylaxis (PP), patients who received a single dose of enoxaparin preoperatively, and extended prophylaxis (EP), patients who received 28 days of enoxaparin postoperatively., Results: In total, 148 patients were included, with 117 patients in the PP group and 31 patients in the EP group. The overall incidence of VTE within 30 days postoperatively was 0.67%. No significant difference was found between the PP and the EP groups (0.9% and 0%, respectively; P = 1.00). Most patients in the cohort had endometrioid adenocarcinoma (78%) with low-grade disease (70%), although there were a greater number of patients in the PP group with uterine serous carcinoma compared with the EP group (17% vs 10%; P = 0.034). The PP group had higher estimated blood loss (106 vs 81 mL; P = 0.009) and longer operative times (178 vs 151 min; P = 0.028) compared with the EP group. Significantly more patients in the PP group underwent lymph node dissection compared with the EP group (32% vs 7%; P = 0.008)., Conclusions: The incidence of VTE following robot-assisted surgical staging for endometrial cancer in this study was 0.67%. No significant difference was found in VTE incidence between the PP group compared with the EP group. Mechanical prophylaxis plus a single dose of preoperative pharmacologic prophylaxis may suffice for low-risk patients following robotic surgical staging for endometrial cancer.
- Published
- 2023
- Full Text
- View/download PDF
4. Secondary cytoreductive surgery in recurrent clear cell carcinoma of the endometrium: A case report.
- Author
-
Cheng C, Jenkins N, Aikman N, and ElSahwi K
- Abstract
Introduction & Importance: Endometrial cancer with high-risk histology is associated with a majority of recurrences and death. However, unlike other cancers, such as ovarian, there is a paucity of research demonstrating the benefits of secondary cytoreduction. In this case report we aim to aid in identifying individuals who may be ideal candidates for secondary cytoreduction surgery after minimally invasive hysterectomy and staging by a gynecologic oncologist at an academic institution and diagnosed with clear cell endometrial cancer., Case Presentation: A 72 year-old female patient presented with postmenopausal bleeding and was subsequently diagnosed with Stage IIIC2 clear cell carcinoma of the endometrium. She represented 20 months after receiving initial staging and adjuvant chemotherapy with increasing CA-125 levels and radiographic evidence of left para-aortic lymph node oligo metastasis. She underwent secondary cytoreductive surgery via robotic-assisted laparoscopic para-aortic lymph node dissection and salvage chemotherapy. After 45 months of follow-up physical exam, CA-125 levels and CT of the abdomen and pelvis have remained without evidence of disease., Clinical Discussion: We review the literature on secondary cytoreductive surgery (SCS) in endometrial cancer (EC) to identify factors associated with improved survival., Conclusion: Secondary cytoreduction in endometrial cancer may lead to prolonged progression-free survival in well-selected patients., Competing Interests: Conflict of interest statement None of the authors have conflict of interest., (Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
5. An audit of adherence to cervical cancer screening guidelines in a tertiary-level HIV clinic.
- Author
-
Bolon J, Samson A, Irwin N, Murray L, Mbodi L, Stacey S, Aikman N, Moonsamy L, and Zamparini J
- Abstract
Background: Cervical cancer is the most common malignancy affecting South African women aged 15-44 years, with a higher prevalence among women living with HIV (WLWH). Despite recommendations for a screening target of 70%, the reported rate of cervical cancer screening in South Africa is 19.3%., Objectives: To investigate the adherence of healthcare workers to cervical cancer screening guidelines in a tertiary-level HIV clinic., Method: A retrospective cross-sectional record audit of women attending the Charlotte Maxeke Johannesburg Academic Hospital HIV Clinic over a 1-month period., Results: Out of 403 WLWH who attended the clinic, 180 (44.7%) were screened for cervical cancer in the 3 years prior to the index consultation. Only 115 (51.6%) of those women with no record of prior screening were subsequently referred for screening. Women who had undergone screening in the previous 3 years were significantly older (47 years vs 44 years, P = 0.046) and had a longer time since diagnosis of their HIV (12 years vs 10 years, P = 0.001) compared to women who had not undergone screening. There was no significant difference in CD4 count or viral suppression between women who had and had not undergone screening., Conclusion: The rate of cervical cancer screening in our institution is below that recommended by the World Health Organization and the South African National Department of Health., Competing Interests: The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article., (© 2023. The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
6. Sex cord stromal tumor presenting with hair loss in postmenopausal women.
- Author
-
Cheng CW, ElSahwi K, Borowsky ME, Aikman N, and Hicks V
- Subjects
- Alopecia etiology, Female, Humans, Postmenopause, Ovarian Neoplasms, Sex Cord-Gonadal Stromal Tumors complications, Sex Cord-Gonadal Stromal Tumors diagnosis, Sex Cord-Gonadal Stromal Tumors pathology
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.